Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease
Yoshimasa Aso, Masaaki Sagara, Takafumi Niitani, Kanako Kato, Toshie Iijima, Takuya Tomaru, Teruo Jojima, Isao Usui
DOI: 10.1136/jim-2020-001621 Published 27 September 2021
Yoshimasa Aso
Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan
Masaaki Sagara
Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan
Takafumi Niitani
Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan
Kanako Kato
Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan
Toshie Iijima
Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan
Takuya Tomaru
Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan
Teruo Jojima
Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan
Isao Usui
Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi, Japan
Submit a Response to This Article
No eLetters have been published for this article.
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease
Yoshimasa Aso, Masaaki Sagara, Takafumi Niitani, Kanako Kato, Toshie Iijima, Takuya Tomaru, Teruo Jojima, Isao Usui
Journal of Investigative Medicine Oct 2021, 69 (7) 1324-1329; DOI: 10.1136/jim-2020-001621
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease
Yoshimasa Aso, Masaaki Sagara, Takafumi Niitani, Kanako Kato, Toshie Iijima, Takuya Tomaru, Teruo Jojima, Isao Usui
Journal of Investigative Medicine Oct 2021, 69 (7) 1324-1329; DOI: 10.1136/jim-2020-001621
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease
Yoshimasa Aso, Masaaki Sagara, Takafumi Niitani, Kanako Kato, Toshie Iijima, Takuya Tomaru, Teruo Jojima, Isao Usui
Journal of Investigative Medicine Oct 2021, 69 (7) 1324-1329; DOI: 10.1136/jim-2020-001621